Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 7Fallopian Tube Neoplasms 6Breast Neoplasms 6Neoplasms 4Sarcoma 3Triple Negative Breast Neoplasms 2Neoplasm Metastasis 2Multi-centric Castleman's Disease 2Lymphoma, B-Cell 2Sarcoma, Kaposi 1Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Lymphoma 1Lymphadenopathy 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Invasive Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1HIV Infections 1Glioma 1Fallopian Tube Mucinous Adenocarcinoma 1

Interventions

pomalidomide 1liposomal doxorubicin 1cabozantinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sarcoma, Kaposi × liposomal doxorubicin × Clear all
NCT02659930 2026-06-04

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
62 enrolled
Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡